{"id":"tp-31286","type":"article-newspaper","title":"Johnson & Johnson Shares Drop More Than 5% Despite Higher 2026 Outlook","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/31286","datePublished":"2026-10-13T15:39:18.000Z","dateModified":"2026-10-13T15:39:18.000Z","language":"en","abstract":"Third-quarter sales rose 5.9% to $25.399 billion, while MedTech growth lagged pharmaceutical gains. The company raised its 2026 outlook.","section":"Business","references":[]}